Eva Jouve

505 total citations
40 papers, 284 citations indexed

About

Eva Jouve is a scholar working on Cancer Research, Surgery and Oncology. According to data from OpenAlex, Eva Jouve has authored 40 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cancer Research, 18 papers in Surgery and 17 papers in Oncology. Recurrent topics in Eva Jouve's work include Breast Cancer Treatment Studies (24 papers), Breast Implant and Reconstruction (11 papers) and Reconstructive Surgery and Microvascular Techniques (8 papers). Eva Jouve is often cited by papers focused on Breast Cancer Treatment Studies (24 papers), Breast Implant and Reconstruction (11 papers) and Reconstructive Surgery and Microvascular Techniques (8 papers). Eva Jouve collaborates with scholars based in France, Canada and Qatar. Eva Jouve's co-authors include Eliane Mery-Lamarche, Denis Querleu, Alejandra Martínez, Monique Cohen, Arash Rafii, Gwénaël Ferron, Ruby Yun‐Ju Huang, Joel A. Malek, Jean Paul Thiery and Denis Querleu and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

Eva Jouve

36 papers receiving 279 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Jouve France 10 153 107 69 60 58 40 284
Marie‐Pierre Chauvet France 11 176 1.2× 96 0.9× 43 0.6× 97 1.6× 120 2.1× 26 299
Mahsa Vahdatinia United States 9 76 0.5× 87 0.8× 40 0.6× 50 0.8× 46 0.8× 15 223
Natalia Krawczyk Germany 9 146 1.0× 105 1.0× 45 0.7× 90 1.5× 58 1.0× 38 299
Kapil Kumar India 10 79 0.5× 121 1.1× 69 1.0× 55 0.9× 99 1.7× 33 275
Mei Cao China 8 85 0.6× 160 1.5× 71 1.0× 14 0.2× 30 0.5× 15 321
J.-M. Nogaret Belgium 8 142 0.9× 189 1.8× 29 0.4× 48 0.8× 75 1.3× 17 322
Samreen Naz Pakistan 11 50 0.3× 117 1.1× 45 0.7× 42 0.7× 103 1.8× 16 298
Jean-Marc Cohen United States 9 89 0.6× 59 0.6× 67 1.0× 112 1.9× 117 2.0× 13 293
Elisabet Sanchez United Kingdom 11 102 0.7× 268 2.5× 97 1.4× 36 0.6× 49 0.8× 19 512
Qin Shi China 11 150 1.0× 81 0.8× 59 0.9× 13 0.2× 43 0.7× 28 380

Countries citing papers authored by Eva Jouve

Since Specialization
Citations

This map shows the geographic impact of Eva Jouve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Jouve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Jouve more than expected).

Fields of papers citing papers by Eva Jouve

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Jouve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Jouve. The network helps show where Eva Jouve may publish in the future.

Co-authorship network of co-authors of Eva Jouve

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Jouve. A scholar is included among the top collaborators of Eva Jouve based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Jouve. Eva Jouve is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ung, Mony, et al.. (2025). Is Immediate Breast Reconstruction an Option for Elderly Women? A Comparative Study Between Elderly and Younger Population. Clinical Breast Cancer. 25(4). e440–e449. 1 indexed citations
2.
Chaltiel, Léonor, et al.. (2024). Oncologic safety of autologous fat grafting in primary breast reconstruction after mastectomy for cancer. European Journal of Surgical Oncology. 50(4). 107998–107998. 2 indexed citations
3.
4.
Houvenaeghel, Gilles, Jean‐Marc Classe, Pierre‐Emmanuel Colombo, et al.. (2024). Eligibility for Adjuvant Cyclin-Dependent Kinase 4/6 Inhibitors in Endocrine Receptor-Positive and HER2-Negative Early Breast Cancer by Age and Type of Surgery. Cancers. 16(19). 3317–3317. 1 indexed citations
5.
Houvenaeghel, Gilles, Monique Cohen, Anthony Gonçalvès, et al.. (2023). Triple-negative and Her2-positive breast cancer in women aged 70 and over: prognostic impact of age according to treatment. Frontiers in Oncology. 13. 1287253–1287253. 4 indexed citations
6.
Houvenaeghel, Gilles, Monique Cohen, Christelle Fauré, et al.. (2023). Early breast cancer in women aged 35 years or younger: A large national multicenter French population-based case control-matched analysis. The Breast. 68. 163–172. 7 indexed citations
7.
Cabarrou, Bastien, R. Aziza, Eva Jouve, et al.. (2022). Systemic treatment with or without ablative therapies in oligometastatic breast cancer: A single institution analysis of patient outcomes. The Breast. 67. 102–109. 5 indexed citations
8.
Aziza, R., C. Chira, Eva Jouve, et al.. (2021). Diagnosis, biology and epidemiology of oligometastatic breast cancer. The Breast. 59. 144–156. 6 indexed citations
9.
Gangloff, D., et al.. (2020). Axillary node dissection in outpatient procedure, is it feasible and safe?. Journal of Gynecology Obstetrics and Human Reproduction. 50(5). 101931–101931. 1 indexed citations
10.
Massabeau, Carole, et al.. (2020). Oral mucosal changes induced by adjuvant endocrine therapies in breast cancer patients: clinical aspects and proposal for management. Supportive Care in Cancer. 29(4). 1719–1722. 6 indexed citations
11.
Chira, C., R. Aziza, Eva Jouve, et al.. (2020). 320P Oligometastatic breast cancer incidence and clinical presentation at diagnosis: About 131 cases. Annals of Oncology. 31. S371–S371. 1 indexed citations
12.
Massabeau, Carole, et al.. (2020). Fracture de côte suite à la radiothérapie peropératoire dans le cancer du sein. Cas clinique et expérience locale. Cancer/Radiothérapie. 24(1). 64–66. 1 indexed citations
13.
Nonneville, Alexandre de, Camille Jauffret, Anthony Gonçalvès, et al.. (2019). Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefit. Breast Cancer Research and Treatment. 175(2). 379–387. 19 indexed citations
14.
Cabarrou, Bastien, Eva Jouve, Camille Franchet, et al.. (2019). Long-Term Follow-up of Immediate Latissimus Dorsi Flap Reconstruction After Neoadjuvant Chemotherapy and Radiotherapy for Invasive Breast Cancer. Clinical Breast Cancer. 19(4). e540–e546. 4 indexed citations
15.
Tournier, É., B. De Lafontan, A. Modesto, et al.. (2017). Dermatoses réactionnelles rares après radiothérapie : une série de cas avec cancer du sein. Cancer/Radiothérapie. 21(3). 216–221. 4 indexed citations
16.
Filleron, Thomas, Léonor Chaltiel, Eva Jouve, et al.. (2017). Les nomogrammes dans la pratique clinique : méthodologie, limites et intérêts. Bulletin du Cancer. 105(1). 15–24. 4 indexed citations
17.
Nonneville, Alexandre de, Anthony Gonçalves, Christophe Zemmour, et al.. (2017). Adjuvant chemotherapy in pT1ab node-negative triple-negative breast carcinomas: Results of a national multi-institutional retrospective study. European Journal of Cancer. 84. 34–43. 29 indexed citations
18.
Malek, Joel A., Alejandra Martínez, Eliane Mery-Lamarche, et al.. (2012). Gene expression analysis of matched ovarian primary tumors and peritoneal metastasis. Journal of Translational Medicine. 10(1). 121–121. 20 indexed citations
19.
Mery-Lamarche, Eliane, Eva Jouve, Maxime Bourgognon, et al.. (2011). Intraoperative fluorescence imaging of peritoneal dissemination of ovarian carcinomas. A preclinical study. Gynecologic Oncology. 122(1). 155–162. 20 indexed citations
20.
Malek, Joel A., Eliane Mery-Lamarche, Eman K. Al‐Azwani, et al.. (2011). Copy Number Variation Analysis of Matched Ovarian Primary Tumors and Peritoneal Metastasis. PLoS ONE. 6(12). e28561–e28561. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026